AnaptysBio, Inc. Common Stock

ANABNASDAQ • USD
NaN USD
↘ NaN (NaN%)🔴AT CLOSE (AS OF 03:45 AM EST)
🔴Market: CLOSED

AnaptysBio, Inc. Common Stock (ANAB) trades at $NaN per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, exceptional Return on Equity (402.1%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place ANAB at a fair price relative to peers.

Technical & fundamental data as of Nov 16, 2026.

Open?N/A
High?N/A
Low?N/A
Prev. Close?$45.73
Volume?0
Avg. Volume?441.0K
Bid / Ask
Bid?$41.54 × 100
Ask?$53.25 × 500
Spread?$11.71
Midpoint?$47.39
Valuation & Ratios
Market Cap?1.4B
Shares Out?29.7M
Float?17.6M
Float %?59.0%
P/E Ratio?16.24
P/B Ratio?65.30
EPS?$2.82
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Employees
104
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2017-01-26
Address
10770 WATERIDGE CIRCLE, SUITE 210
SAN DIEGO, CA 92121
Phone: 858-362-6295
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
87
Momentum?
57
Short Sent.?
35
Piotroski F-Score?3/9Weak
Altman Z-Score?3.68Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?28.65%Squeeze Risk
Short Interest?5.1M
Days to Cover?10.8
Free Float17.6M
Avg Daily Volume468.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.40Strong
Quick Ratio?8.40Strong
Cash Ratio?6.04Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
Peers
100
S&P
77
16.2CHEAP▾
P/B?
Peers
100
S&P
3
65.30HIGH▾
P/S?
Peers
100
S&P
32
4.67FAIR▾
P/FCF?
Peers
100
S&P
17
40.3PRICEY▾
EV/EBITDA?
Peers
100
S&P
97
6.2CHEAP▾
EV/Sales?
Peers
100
S&P
44
4.20FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
402.1%STRONG▾
ROA?
Peers
50
S&P
97
27.3%STRONG▾
Cash Flow & Enterprise
FCF?$33.7M
Enterprise Value?$1.2B
Fundamentals ratios updated end of day